CN115058397A - 一种牛肠道病毒分离株及其应用 - Google Patents

一种牛肠道病毒分离株及其应用 Download PDF

Info

Publication number
CN115058397A
CN115058397A CN202210114436.8A CN202210114436A CN115058397A CN 115058397 A CN115058397 A CN 115058397A CN 202210114436 A CN202210114436 A CN 202210114436A CN 115058397 A CN115058397 A CN 115058397A
Authority
CN
China
Prior art keywords
leu
val
ala
gly
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210114436.8A
Other languages
English (en)
Inventor
潘子豪
季程远
马家乐
姚火春
王凯民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Agricultural University
Original Assignee
Nanjing Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Agricultural University filed Critical Nanjing Agricultural University
Priority to CN202210114436.8A priority Critical patent/CN115058397A/zh
Publication of CN115058397A publication Critical patent/CN115058397A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32311Enterovirus
    • C12N2770/32321Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32311Enterovirus
    • C12N2770/32322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32311Enterovirus
    • C12N2770/32341Use of virus, viral particle or viral elements as a vector
    • C12N2770/32343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

一种牛肠道病毒分离株及其应用,该病毒的分类命名为牛肠道病毒bovine enterovirus(BEV),该病毒已于2020年7月17日在中国典型培养物保藏中心(CCTCC)进行的保藏,保藏编号为CCTCC NO:V202028。本发明中的病毒HB1901可在MDBK细胞中高效增殖,病毒浓度可达106.0TCID50/mL,无外源病毒污染;所构建的感染性克隆质粒可直接转染至真核细胞中,无需转录成RNA后再转染,操作简便,成本低廉;携带外源绿色荧光蛋白GFP,并可在细胞中稳定表达。

Description

一种牛肠道病毒分离株及其应用
技术领域
本发明属于病毒分子生物学和基因克隆技术领域,具体涉及一种牛肠道病毒分离株及其应用。
背景技术
牛肠道病毒(Bovine enterovirus,BEV)属于小RNA病毒科,肠道病毒属,近年来在中国牛场中广泛传播。牛肠道病毒感染与牛的腹泻和呼吸道疾病相关。本发明中选用的牛肠道病毒HB1901毒株是在河北某牧场爆发严重腹泻的牛群中分离出来的,经基因分析后发现其属于BEV-F型。由于牛肠道病毒致病力较低,且稳定性好,是构建病毒载体的理想毒株。此外反向遗传系统是研究病毒复制机制、致病机理和疫苗研发的重要工具。
BEV的反向遗传方面,2013年于力等人通过在5’端引入T7 RNA聚合酶进行细胞外转录,构建了牛肠道病毒cDNA感染性克隆。随后在牛肠道病毒VP1基因B-C loop和D-E loop中分别插入口蹄疫病毒(O型)的保守中和表位8E8,得到的重组病毒可以拯救成功,并且可以稳定传代。肌肉接种小鼠后,可在小鼠体内引起抗口蹄疫病毒的IgG抗体,该结果表明BEV可作为疫苗载体。此外张海丽等人,张姗等人以及刘丹等人均通过引入T7启动子构建了BEV的反向遗传操作系统。在已有的BEV感染性克隆中都是以T7启动子体外转录的操作系统,而本发明中构建的系统是基于CMV真核表达启动子的,该系统的优势在于不需要在体外将质粒转录成RNA后再转染至细胞,可直接将质粒转染至细胞中,此操作过程大大简便且极大地节约了成本。此外,本发明是国内外首次成功将绿色荧光蛋白GFP插入到BEV中,这不仅可以对病毒进行可视化分析,同时也表明BEV可容纳更大的外源基因片段,这对研发BEV 的基因工程疫苗提供了支持。
发明内容
解决的技术问题:本发明提供一种牛肠道病毒分离株及其应用,为研究BEV复制机制、致病机理和疫苗研发提供了重要工具,还可为其他肠道病毒属或者RNA病毒的反向遗传学系统的构建和研究提供科学参考。
技术方案:一种牛肠道病毒分离株HB1901,该病毒的分类命名为牛肠道病毒bovine enterovirus(BEV),该病毒已于2020年7月17日在中国典型培养物保藏中心(CCTCC)进行的保藏,保藏编号为CCTCC NO:V202028。地址:湖北省武汉市武昌区八一路299号。
上述牛肠道病毒分离株HB1901的基因,序列如SEQ ID NO.1所示。
上述牛肠道病毒分离株HB1901的基因,所述病毒的基因序列中插入有GFP。
含有上述牛肠道病毒分离株HB1901的载体。
上述牛肠道病毒分离株HB1901基因翻译的氨基酸序列,序列如SEQ ID NO.2所示。
含有上述载体的重组菌或重组细胞。
上述重组细胞为牛肾细胞。
上述牛肠道病毒分离株HB1901在构建病毒载体中的应用。
具体内容为:
1、从牛粪便样品中分离出牛肠道病毒。
2、对病毒粒子进行电镜观察(图1)。
3、在感染病毒的细胞上清液中提取BEV的基因组。
4、通过PCR扩增了覆盖整个病毒基因组的三个片段,然后组装到低拷贝载体pBluescript skII。同时在病毒基因组5'端有CMV启动子,此元件主要用于在真核细胞中启动DNA转录。随后在此基础上,在基因组5’UTR和VP4基因之间利用SOE PCR引入外源绿色荧光蛋白GFP,构建了p-GFP-HB1901的全长感染性克隆(图2图3)。
5、将构建好的重组质粒进行全长测序,与原毒株HB1901全长序列相比发现存在6个核苷酸突变(表1)。随后将质粒转染至BHK-21细胞中,转染后48h即可见到绿色荧光(图4),测定病毒滴度达到105.1TCID50/mL。转染得到的重组病毒r-GFP-HB1901在BHK-21细胞中传代三次后得到第三代病毒,提取病毒上清RNA并进行测序,未发现新的突变,表明 r-GFP-HB1901重组病毒可以在细胞中传代后保持遗传稳定。
表1
Figure RE-GDA0003785586320000021
6、将重组的r-GFP-HB1901病毒和原毒株HB1901在MDBK细胞中进行噬斑试验,发现重组病毒在体外感染细胞系后,滴度略低于亲代病毒(图5)。
7、将重组的r-GFP-HB1901病毒在BHK-21细胞中的复制曲线和亲代病毒在细胞上的复制曲线进行比较,发现重组病毒在体外感染细胞系后,病毒的复制效率略低于亲代病毒(图 9)。
有益效果:本发明中的病毒HB1901可在MDBK细胞中高效增殖,病毒浓度可达106.0TCID50/mL,无外源病毒污染;所构建的感染性克隆质粒可直接转染至真核细胞中,无需转录成RNA后再转染,操作简便,成本低廉;携带外源绿色荧光蛋白GFP,并可在细胞中稳定表达。
附图说明
图1为本发明中牛肠道病毒细胞病变图(左为细胞病变,右为阴性细胞);
图2为本发明中病毒粒子电镜图(左为100nm电镜图,右为50nm电镜图);
图3为本发明中感染性克隆构建示意图;
图4为本发明中PCR扩增图;(M为MARKER;1为CMV启动子;2为分段1;3为分段2;4为分段3;N为阴性对照);
图5为本发明中克隆株绿色荧光表达图;
图6为间接免疫荧光图;
图7为Western Bloting图;
图8为空斑图(左图为亲本株,右图为克隆株);
图9为克隆株与亲本株生长曲线图。
具体实施方法
下面结合具体实施例对本发明作进一步解释,但是应当注意的是,以下实施例仅用以解释本发明,而不能用来限制本发明,所有与本发明相同或相近的技术方案均在本发明的保护范围之内。若未特别指明,实施例中所用的技术手段为本领域技术人员所熟知的常规手段,所用原料为市售商品。
构建方案:通过选择BstZ17 I和EcoR V这两个个酶切位点将整个病毒分为3个部分,利用同源重组的方式将3个片段连接在一起,随后通过重叠PCR在病毒5’端前引入CMV启动子。拯救成功后,在5’UTR和VP4基因之间插入GFP,最终得到p-GFP-HB1901全长感染性克隆。
实施例1
病毒的分离:自2019年河北省某牛场收集腹泻小牛的粪便标本,经处理后接种至牛肾传代细胞(MDBK)上,培养两代后细胞出现细胞病变,进一步空斑纯化后,获得牛肠道病毒 HB1901,该病毒的分类命名为牛肠道病毒bovine enterovirus(BEV),该病毒已于2020年7 月17日在中国典型培养物保藏中心(CCTCC)进行的保藏,保藏编号为CCTCC NO:V202028。地址:湖北省武汉市武昌区八一路299号。
病毒的序列分析:对该病毒的基因组序列进行分析,全基因序列为SEQ ID NO.1所示的序列(见序列表),其与GenBank中已有的牛肠道病毒的序列相比,核苷酸的同源性在83%以上。
病毒的电镜检查:在电镜下观察牛肠道病毒HB1901,如图1所示,病毒颗粒直径范围在 25-30nm,表面无囊膜。
无菌、支原体检测:按照《中国兽药典》方法对该病毒进行无菌、支原体检查,结果表明无支原体和其它微生物污染。
病毒滴度检测:采用微量滴定法测定该株病毒的病毒浓度,采用方法如下:采用MDBK 细胞进行病毒滴度的测定。用96孔细胞培养板培养MDBK细胞,将病毒用细胞维持液从10-1倍比稀释至10-8,分别将每个稀释度的病毒液接种100μL/孔,每个稀释度接种8孔,将对数生长期的MDBK细胞稀释至2×106个细胞/mL,每个细胞空中接种100μL,同时设细胞对照孔。置37℃,5%CO2培养箱中培养,4-6天观察细胞感染病毒情况,计算病毒浓度,病毒浓度达106.5TCID50/mL。
传代稳定性实验:将病毒HB1901在MDBK细胞上连续传代,每代进行细胞病变观察和 qRT-PCR检测,传代至20代,病毒培养仍可出现典型的细胞病变。qRT-PCR检测结果呈牛肠道病毒阳性,证实该病毒可稳定传代。
使用TRIzol法从病毒液中提取病毒RNA。取200μL病毒液加入无RNase EP管,加入750μL TRIzol试剂,轻轻混匀,室温孵育10分钟后,加入200μL氯仿,振荡混匀,室温静置 3分钟。4℃条件下,12000离心15分钟。取离心后上清至新的无RNase EP管,加入等体积异丙醇,颠倒混匀后室温静置10分钟。4℃条件下,12000rpm离心10分钟。弃去上清,加入l mL75%乙醇,振荡混匀后,4℃条件下,7500rpm离心5分钟。弃去上清,静置离心管等待RNA干燥后,加入20μL无RNase水。测定浓度后,在超低温冰箱保存。
取出Rnase free 0.2mL八连管每孔中分别加入1μL Oligo(dT)和Randomhexamers,再加入 6μL RNA模板,共8μL体系。取上0.2mL八连管短暂离心置于65℃水浴锅加热5min,后迅速置于冰上2min。在以上体系中加入10μL 2×RT Mix和2μL Hiscript EnzymeMix,构成20μL 体系。轻微震荡混匀短暂离心后进行反转录,程序为:25℃5min,50℃40min,85℃2min。反应结束得到的即为转录产物样品模板反cDNA,放于-20℃冰箱保存,备用。在病毒cDNA 基础上进行分段PCR,对PCR产物进行测序,根据测序结果组装完整病毒基因组序列。
转化质粒与扩增。取连接产物5μL,溶于100μL感受态DH5a细胞,冰浴30分钟。42℃热激45秒后置于冰上恢复2min,加无抗性LB培养基450μL,37℃220rpm振荡培养1小时,4000rpm离心3分钟,留约100μL上清重悬菌体,涂布于含100μg/mL氨苄青霉素的LB 固体培养基上,37℃培养16小时。挑取单菌落,加入含100μg/mL氨苄青霉素的LB液体培养基,37℃220rpm振荡培养16小时,用于菌落鉴定。对于pBluescript skII等质粒,取2μL 质粒,溶于100μL感受态细胞,冰浴30分钟。42℃热激45秒后置于冰上恢复2分钟,加无氨苄LB培养基450μL,37℃220rpm振荡培养1小时,4000rpm离心3分钟,留约100μL 上清重悬菌体,涂布于含氨苄青霉素的LB固体培养基上,37℃培养16小时。挑取单菌落,加入含氨苄青霉素的LB液体培养基,37℃220rpm振荡培养16小时,用于质粒提取。
细胞培养及转染。当细胞生长达到密度80%左右即进行传代。洗掉培养基后,用lmL PBS 溶液冲洗1次,弃PBS,加l mL 0.25胰蛋白酶,37℃静置2分钟。加2mL含10%FBS的培养基终止消化,按1:4比例传代,放置于37℃,5%CO2培养箱中培养。转染前将6孔板中每一孔的细胞完全培养基弃去,并用PBS进行清洗。将2μg质粒加入250μL Opti-MEM培养基,将5μL Lipofectamine 2000加入250μL Opti-MEM培养基,在室温条件下孵育10分钟。将含质粒的Opti-MEM培养基加入到含Lipofectamine 2000的培养基中,室温条件下孵育20分钟。将转染溶液加入到6孔板中,37℃下孵育6小时。弃去混有转染溶液的Opti-MEM培养基,每孔加入2mL含有2%FBS的DMEM培养基。
间接免疫荧光。进行间接免疫荧光测定法来检测BEV全长感染性克隆质粒转染的BHK-21细胞中的病毒蛋白表达。在6孔板中,用BEV全长感染性克隆质粒转染的BHK-21 细胞。在指定的时间点,吸取细胞上清,细胞在室温下用4%多聚甲醛固定15分钟。在含有 1%BSA的PBS封闭缓冲液中温育1小时后,加入含有2%Anti-VP2小鼠多克隆抗体的封闭缓冲液,室温孵育2小时。吸去含有抗体的封闭缓冲液后,用PBS洗涤5分钟,共3次。加入含有2%Alexa Fluor 488抗小鼠IgG的封闭缓冲液,室温孵育1小时。吸去含有抗体的封闭缓冲液后,用PBS洗涤5分钟,共3次。在荧光显微镜下观察。
取拯救的重组毒p-GFP-HB1901与亲本病毒HB1901按1个MOI感染24h后的MDBK 细胞培养物进行SDS-PAGE电泳后,用半干转印法将蛋白转印到PVDF膜上。然后将PVDF 膜置于含有50g/L脱脂奶粉的PBS封闭液中封闭过夜,用PBS-T洗膜三次,每次5min;加入鼠抗HB1901-VP2(1:1000)作为一抗,室温孵育2h,用PBS-T洗三次,每次5min;再与HRP 标记的羊抗鼠Ig G为二抗,室温孵育1h用PBST彻底洗涤后进行成像系统分析。
噬斑形成实验。使用噬斑测定来确定BEV的感染性滴度。感染实验前24小时,将MDBK 细胞按照每孔2×105铺到6孔板中。将含有病毒的培养物上清液在DMEM中连续稀释10倍,从101至106倍。对于每种稀释液,将500μL稀释的病毒液加入培养至约90%汇合度的MDBK细胞的12孔板的孔中。将加有病毒液的细胞在37℃和5%CO2条件下孵育2小时,并每15 分钟摇动孔板以确保病毒稀释液完全覆盖细胞单层以获得均匀感染。孵育后,用PBS洗涤细胞单层以去除未吸附的病毒后,每孔加入2mL含低熔点琼脂的培养基(2%低熔点琼脂糖和 2×DMEM 1:1混合),并将孔板在37℃和5%CO2条件下培养48-72h。每孔加入500μL结晶紫染色液对其进行固定并染色,并在室温下静置60分钟。用水轻轻冲洗掉琼脂。计数可见斑块,并据此计算病毒滴度。
将亲本毒和重组毒株按照0.05MOI分别接种于MDBK细胞上,37℃感作2h,用PBS洗去未吸附的病毒,加入含有2%FBS的DMEM培养基,再接毒后6,12,24,36和48h取样,反复冻融3次,收获病毒液,测定取样时间的病毒TCID50。并制作病毒的生长曲线。
最后应当说明的是,以上实施例仅用以说明本发明的技术方案而非对本发明保护范围的限制,尽管参照较佳实施例对本发明做了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的实质和范围,均属于本发明要求保护的范围。
序列表
<110> 南京农业大学
<120> 一种牛肠道病毒分离株及其应用
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 7356
<212> DNA
<213> 人工序列(Artificial Sequence)
<400> 1
ggttgttccc acccctgggg cccacgcggc gccagtactc tggtacgtta gtacctttgt 60
acgcctgttt tcccttccct taaacaaatt aagattacca ctactgaggg gagtagtccg 120
actccgctcc agcactgctg caccagtgaa ttggtacgcc agtacctctg cacggagtag 180
atggtattcc cgccccgtaa cttagaagca aagcacataa ccgaccaata gcggcaccgc 240
atccagctgt gcaacggtca agcacttctg tctccccggt ctacaaggat cgttacccgc 300
ccgggccact acgagaagcc tattaactac tgaagcagtc tagaggttgc gcccaaccac 360
aaccccagtg gtagctctga gtgatggggc tcgcagttcc cccatggtaa catggttgct 420
tgcccgcgcg tgcactcggg ttcggccttg tgccgttcac ctcaaaactg tctaagtagc 480
caagagccta ttgtgctggt ctggttttcc tccggagccg tgaatgctgc taatcccaac 540
ctccgagcgt gtgcgcacaa tccagtgttg ctacgtcgta acgcgtaagt tggaggcgga 600
acagactact ttcggtactc cgtgtttcct ttgttttaat tctcaaactt tatggtgaca 660
attgttgaga tttgcaactt agcgacttta ccgttgaaca tcgccttgta ttacctagtt 720
gcattccaca agacttctaa tattcccagc ccttacattg atttgctagt ctttctcaac 780
ctcaagcaca aattggagaa gttaagatgg gagcacaagt gagcaagaac actgctggat 840
cccacaccac tggaacatat gccaccggtg gctccaacat ccactacact aacatcaatt 900
actatgagaa tgctgcttca aacagcttga acaagcagga tctaactcag gacccagaaa 960
agttcactag gcctgtggtt gatgtcatga aggaggcagc tgtccccctc aagagccctt 1020
ctgctgaagc ctgtggatac agtgacagag tggctcaatt gactctaggc aactccacca 1080
taacgaccca agaggcggcc aatattgtgg ttgcgtatgg taagtggcca acaacccttc 1140
gggatgatga tgctacggca gttgataagc ccaccgaacc cggggtcagc gctgaacgct 1200
tctatacgct gccatcggtg cagtggaccg ggacctttaa aggccagttc tggaaattgc 1260
ccgacgctct caccgaattg gggatgttcg ggcaaaactt acagttccac tacctctaca 1320
ggggcggctg ggcaatacac gttcagtgta atgccacaaa gtttcaccaa ggaacgctct 1380
tggttgttgc cattccggag cacaagatac agtcacagca gacgcctgac tttaataaaa 1440
caaatccagg tgagaatggg tttcaattcc agtttccttt cacccttgag gatgggtcgg 1500
cgctgggcaa tgcacttgtt tacccgcatc aatggatcaa tctgcgaacc aacaactctg 1560
ccaccctgat tctcccgtat gtcaacgctg ttccaatgga ttcaggaatt agacacaaca 1620
attggacgct agcagttata cccctcgtgc ctcttatgta cgctgaggga tccaccacct 1680
acgttccaat cacagtcact atagcaccaa tgtgcactga gttcaatggg ttgaggagag 1740
cggtagcgca gggggttccc acaatgttca cacccggttc aggacaattt ctgactacgg 1800
acgactacca gtcaccgtgc atcctaccaa agttcaaacc aaccccaatg attgacatac 1860
ctggtgaggt gaaaaacatt ctagagattg ttcaggttga gagccttgtc gaaatccaga 1920
atgtggaaaa cgtcaacggt gtggagcgat acaggatccc gctgagcgta caagacgaaa 1980
tggaccaaca aatcatggcg ctcagggtgg acccagggac caatgggcca ctgcagtcta 2040
ctctgcttgg tgtgttcact cgctactaca cgcagtggtc ggggtcgatt gaatttacgt 2100
tcatgttctg tggtaccttt atgtccaccg gaaaagtcgt gattgcttac acaccacctg 2160
gcgggaccgc accaactagc aggagagagg caatgcttgg tactcacata gtatgggatt 2220
ttgggctcca gtcgtcaatc accctagtgg taccatggat ctcttcgggt catttccgcg 2280
cggcagacat caacgccaca ctctttaagt acaagtacta tgaggcggga tttgtaacta 2340
tgtggtacca gaccaacctc gtagtgccgc cccagttccc aaatgaggcg tccattctga 2400
tgtttgtggc agcacaaccc aatttctcaa tgcgcatcat gaaggaccga cctgagattg 2460
cccagaccgc ggctctccag ggcgagacgg gacttgcaat caaagatgct gttcataaaa 2520
ctgttaagga cacagtggaa tcccaccata ccattagcac agagagtacc cccgcgctac 2580
aagccgcgga aactggtgcc acatcaaatg ctagcgatga gagcctcatt gagacgcgga 2640
atgtcgtcaa cacgcacggt gtggaggaga cctcgatcga ggcattcttc gggcgctctg 2700
gtttggttgg catggccccg actgttggtg gcatcggacg ctggatcgtg aacttcggtg 2760
agtttgttca ggtacgcgca aaacttgaga tgttcacata tgtgcgcttt gacattgagc 2820
tcactattgt agcagaggtc cttacacagg atgggaacaa agttgcacat cagcatgtga 2880
attaccaagt tatgtacgtt cccccgggcg ctagtgaacc tgaaaaccaa gattctttcc 2940
agtggcagtc gtcttgtaat ccctcagtga tctcaaacac ggccgcgcca cccgcacgcg 3000
tatccatccc cttcatgagc actgcgaatg cgtattcaat gtcctacgat gggtacgcaa 3060
cctttgatga caaggcgggt tcaaattatg gaatggtgcc atcaaattat cttggaacaa 3120
ttgtgtttcg cacaatggaa gatctcgacc gaaaactgct gaaggtgcgg ttttatgcca 3180
aaccgaagca tgtgcggtgt tggatcccac gcgctccacg cgcggtgccc tataaaagca 3240
ggtacactgg tgtctacgac accgttgaga agttctgtga caatcgtgct aatattaaaa 3300
cagcaggggc ttttggccaa caaagcgggg cggcctacgt cggaaactac aagatcatga 3360
accgacacct ggccgagaag caagactggg acaatcttgt gtgggattct tatgagaggg 3420
acctgctcgt cacccgcgtt gacgcccacg gggtggacca gatcgccagg tgtaattgcc 3480
gtgctggtgt atactattgc aagtccagga tgaggcacta ccctgtagtt gtgaccccac 3540
ctagcctcgt tcatattgac aagaacggtt attaccctga gaggtaccag tcacacgtgg 3600
cgctgggaat tggctttgct gaacccggtg attgtggtgg cctcctgagg tgtgagcatg 3660
gcgtgatggg gattcttacc gccggtggga ataacctggt ggcctttgca gatgttagag 3720
atcttctttg gattgaagat gatgttatgg agcaggggct tactgactat gttcaaagcc 3780
tgggcaacgc ctttggcgct ggtttcactg atgaaatttc caattacgtt ggtcaagtca 3840
gggacatgat gattgggagt gataccgtgg tggagaagat agttagaaat atcattaaac 3900
ttctttccgc cttagtcatt gtggtgagga accgtgccga catcatcact gtcaccgcca 3960
ctctgtctct cctcgggtgt tccggttcac cctggcgttg gttgaaatct aaaatttgct 4020
ccattctagg catcaatatg gcccaaaaac aggcagatag ctggatcaaa aagttcactg 4080
aggctgtgaa cgctttcaag ggactcgatt ggattgcagc taagttttcc aagttccttg 4140
attggataaa gtccaaaatc atcccagaac tcagagagag gacggagttt gtgaaaaatc 4200
tgaggcagct cccgcttctt gaggcccaga ttaccactct cgaacattcc aatccgaacc 4260
aggagaccca ggagaccctg ttttcaaatg tacagtatct tgcccaccat tgtaggaaga 4320
acgccccact gtacgcagct gaggcccgca gggtcttcgc tctggagaag cgtgtgctgg 4380
gggcaatgca gttcaagacc aagaatcgaa ttgaacctgt ttgctgccta atccacggta 4440
ctccaggcac cggtaagtct cttgcaacca ccattattgg cagaaagatc gctgagtatg 4500
aaaacagcgg tgtctacagt ctaccacccg accctgatca ctttgatggt taccaagaac 4560
aggctgttgt gataatggat gatctccatc aaaacccaga tggtaaggat atgagcttat 4620
tttgccagat ggtgtccacc accccttttg ttgttccaat ggctgcgcta gaagacaagg 4680
gcaggctttt cacttccaag tatgtgcttg catcgacaaa cgccaaccac atccaccccg 4740
tcaccgtcgc tgatgggaaa gctcttcagc gcaggtttca ttttgacacc gatattgaga 4800
ttatggacgg ttatgtgcag aatggtaagc ttaacattca gaaagcaact gagtcgtgtg 4860
aggattgctc acccatcaac ttccaaaagt gcatgccctt gatttgtgga aaggccctcc 4920
aactccgcag caagaaaggt gatggcatga ggtatagcat tgacaccatg atcacagaaa 4980
tgcgccgtga gtctgctagg cgttataaca ttggaaatgt gattgaggca cttttccagg 5040
gacccccgga gttcaagccc ctcaggatag atgtgagcga ggagaccccg gcaccgcctg 5100
ccatcgcaga tcttcttgct agtgtggact ccgaggaggt cagggagtat tgcagaagca 5160
agggctggat cgtgcaagag aaaattacca aggagagcct cgagcgcaac gtcaaccgtg 5220
ctctcattgt cctgcaatcg gcaactctta tcgcaaccat ttgtggtgtc atctacatag 5280
tgtacaaact gtttgcgggt ctccagggtc cctactctgg cattcacaca aattaccaaa 5340
aagtcaagcc cgttgtcaga caggtcacta cacaggggcc tctcgtggac ttcgctgttt 5400
ccttgcttaa gaagaatatc aagacagtgc aaacaaaggt tggtgagttc actggtctgg 5460
gcgtctacga cacttttatg gtgctcccca ggcacgccat ggctcacgat gaaatccaaa 5520
ttgatggaaa gacagtgaag attgaggatg cctacgatct caatgacacc acccaaactt 5580
ccctggagct aaccatcata aaacttaaac agaatgagag gtttagggat atcagggcaa 5640
tgatcccaga gaacatcacg gaaaccagtg aagccctggt tattgtgaac acctcggctt 5700
acccaaatct gttcatgccc gttggcgccg tcaaagatta cggctatctc aacctggccg 5760
gcagacccac ccaccgcacg ctgatgtaca actttccaac cagggctggg cagtgtggtg 5820
gtgttgccat ctctatgggc aaaatcattg gcatccacat cggtggaaac ggtgcgcaag 5880
gctttagcgc cgcgctcctg cgccgctatt tcacccaacc ccaaggggag attgagttca 5940
tggagaagag caaggacgcg ggctacccaa tcatcaatgc tcccacaagg accaagctcc 6000
accccagcgt cttttacgat gtgttcccag gagagaagga gccggccgtg ctacataaga 6060
aagatcccag gctagaggtg gactttgagg aagctctctt ctcgaagtac atcgggaata 6120
agcacatcgc tgttactgag gagatggaga tcgcaattga ccactacgca aatcaactta 6180
agcagttgga cattgacccc agccccatta gcatggagga tgccatttat ggaacagaag 6240
gtctggaggc tttggacctt ggtactagtg caggttaccc ctatgtagca ttgggaatta 6300
agaagaggga catcctcaac aaggagacgc gcgacgtctc caaaatgcaa cagtgcatag 6360
acaagtacgg gcttaacctt cccatggtca cttatgtgaa ggatgagctc cgctcaaagg 6420
agaaagtgaa gaagggcaaa agccggctca ttgaggcgtc gagtctaaac gactccgtcg 6480
cgatgagatg cgccttcgga aatctctata aggcatttca caccaaccct ggaaccctta 6540
ccgggtgcgc cgtgggttgc aatcctgaga ccttttggag caagattcct gtgatgatgg 6600
atggggagct ttttggcttt gactacacag cgtatgatgc cagtctctcc cctgtttggt 6660
ttcagtgtct atatctcctc cttgaaaaga taggattcgg gcactgcaag cattttattg 6720
accaactctg ctgctccaac catctattta tggacaaaag gtacgtcgtt gtcggcggca 6780
tgccttcagg ctgctcgggt actagcatct ttaacagcat gattaacaac atcataatta 6840
gaacactagt ccttacagtc tacaagaata ttgaccttga tgatctcaag atcatcgcat 6900
atggtgatga tgtgattgcc tcttacccgt tcgagctcga tgcaaaactg ctcgccgatg 6960
cggggaagag ctttggtctc atcatgacac caccagacaa aagtgcagag tttgttaaat 7020
tgacctggga taatgtgacc tttttgaaga ggtcgttcgt taaagacgag cgatttccat 7080
tccttatcca tccggttatg aagatgtcag atattcatga gtccatccgt tggaccaagg 7140
atgctaaatc tacccaggat catgttaggt ccctgtgtct attggcttgg cactgtggac 7200
aagaacagta tgaagaattt ctggagaaaa tccggagtgt gcccgtgggc cgggcacttt 7260
cgctgccttc ttttaaagca ctgcagcgct cctggtatga ctccttttaa ctctattcca 7320
atttgaatta tccggtctaa tcagattcta attggc 7356
<210> 2
<211> 2167
<212> PRT
<213> 人工序列(Artificial Sequence)
<400> 2
Met Gly Ala Gln Val Ser Lys Asn Thr Ala Gly Ser His Thr Thr Gly
1 5 10 15
Thr Tyr Ala Thr Gly Gly Ser Asn Ile His Tyr Thr Asn Ile Asn Tyr
20 25 30
Tyr Glu Asn Ala Ala Ser Asn Ser Leu Asn Lys Gln Asp Leu Thr Gln
35 40 45
Asp Pro Glu Lys Phe Thr Arg Pro Val Val Asp Val Met Lys Glu Ala
50 55 60
Ala Val Pro Leu Lys Ser Pro Ser Ala Glu Ala Cys Gly Tyr Ser Asp
65 70 75 80
Arg Val Ala Gln Leu Thr Leu Gly Asn Ser Thr Ile Thr Thr Gln Glu
85 90 95
Ala Ala Asn Ile Val Val Ala Tyr Gly Lys Trp Pro Thr Thr Leu Arg
100 105 110
Asp Asp Asp Ala Thr Ala Val Asp Lys Pro Thr Glu Pro Gly Val Ser
115 120 125
Ala Glu Arg Phe Tyr Thr Leu Pro Ser Val Gln Trp Thr Gly Thr Phe
130 135 140
Lys Gly Gln Phe Trp Lys Leu Pro Asp Ala Leu Thr Glu Leu Gly Met
145 150 155 160
Phe Gly Gln Asn Leu Gln Phe His Tyr Leu Tyr Arg Gly Gly Trp Ala
165 170 175
Ile His Val Gln Cys Asn Ala Thr Lys Phe His Gln Gly Thr Leu Leu
180 185 190
Val Val Ala Ile Pro Glu His Lys Ile Gln Ser Gln Gln Thr Pro Asp
195 200 205
Phe Asn Lys Thr Asn Pro Gly Glu Asn Gly Phe Gln Phe Gln Phe Pro
210 215 220
Phe Thr Leu Glu Asp Gly Ser Ala Leu Gly Asn Ala Leu Val Tyr Pro
225 230 235 240
His Gln Trp Ile Asn Leu Arg Thr Asn Asn Ser Ala Thr Leu Ile Leu
245 250 255
Pro Tyr Val Asn Ala Val Pro Met Asp Ser Gly Ile Arg His Asn Asn
260 265 270
Trp Thr Leu Ala Val Ile Pro Leu Val Pro Leu Met Tyr Ala Glu Gly
275 280 285
Ser Thr Thr Tyr Val Pro Ile Thr Val Thr Ile Ala Pro Met Cys Thr
290 295 300
Glu Phe Asn Gly Leu Arg Arg Ala Val Ala Gln Gly Val Pro Thr Met
305 310 315 320
Phe Thr Pro Gly Ser Gly Gln Phe Leu Thr Thr Asp Asp Tyr Gln Ser
325 330 335
Pro Cys Ile Leu Pro Lys Phe Lys Pro Thr Pro Met Ile Asp Ile Pro
340 345 350
Gly Glu Val Lys Asn Ile Leu Glu Ile Val Gln Val Glu Ser Leu Val
355 360 365
Glu Ile Gln Asn Val Glu Asn Val Asn Gly Val Glu Arg Tyr Arg Ile
370 375 380
Pro Leu Ser Val Gln Asp Glu Met Asp Gln Gln Ile Met Ala Leu Arg
385 390 395 400
Val Asp Pro Gly Thr Asn Gly Pro Leu Gln Ser Thr Leu Leu Gly Val
405 410 415
Phe Thr Arg Tyr Tyr Thr Gln Trp Ser Gly Ser Ile Glu Phe Thr Phe
420 425 430
Met Phe Cys Gly Thr Phe Met Ser Thr Gly Lys Val Val Ile Ala Tyr
435 440 445
Thr Pro Pro Gly Gly Thr Ala Pro Thr Ser Arg Arg Glu Ala Met Leu
450 455 460
Gly Thr His Ile Val Trp Asp Phe Gly Leu Gln Ser Ser Ile Thr Leu
465 470 475 480
Val Val Pro Trp Ile Ser Ser Gly His Phe Arg Ala Ala Asp Ile Asn
485 490 495
Ala Thr Leu Phe Lys Tyr Lys Tyr Tyr Glu Ala Gly Phe Val Thr Met
500 505 510
Trp Tyr Gln Thr Asn Leu Val Val Pro Pro Gln Phe Pro Asn Glu Ala
515 520 525
Ser Ile Leu Met Phe Val Ala Ala Gln Pro Asn Phe Ser Met Arg Ile
530 535 540
Met Lys Asp Arg Pro Glu Ile Ala Gln Thr Ala Ala Leu Gln Gly Glu
545 550 555 560
Thr Gly Leu Ala Ile Lys Asp Ala Val His Lys Thr Val Lys Asp Thr
565 570 575
Val Glu Ser His His Thr Ile Ser Thr Glu Ser Thr Pro Ala Leu Gln
580 585 590
Ala Ala Glu Thr Gly Ala Thr Ser Asn Ala Ser Asp Glu Ser Leu Ile
595 600 605
Glu Thr Arg Asn Val Val Asn Thr His Gly Val Glu Glu Thr Ser Ile
610 615 620
Glu Ala Phe Phe Gly Arg Ser Gly Leu Val Gly Met Ala Pro Thr Val
625 630 635 640
Gly Gly Ile Gly Arg Trp Ile Val Asn Phe Gly Glu Phe Val Gln Val
645 650 655
Arg Ala Lys Leu Glu Met Phe Thr Tyr Val Arg Phe Asp Ile Glu Leu
660 665 670
Thr Ile Val Ala Glu Val Leu Thr Gln Asp Gly Asn Lys Val Ala His
675 680 685
Gln His Val Asn Tyr Gln Val Met Tyr Val Pro Pro Gly Ala Ser Glu
690 695 700
Pro Glu Asn Gln Asp Ser Phe Gln Trp Gln Ser Ser Cys Asn Pro Ser
705 710 715 720
Val Ile Ser Asn Thr Ala Ala Pro Pro Ala Arg Val Ser Ile Pro Phe
725 730 735
Met Ser Thr Ala Asn Ala Tyr Ser Met Ser Tyr Asp Gly Tyr Ala Thr
740 745 750
Phe Asp Asp Lys Ala Gly Ser Asn Tyr Gly Met Val Pro Ser Asn Tyr
755 760 765
Leu Gly Thr Ile Val Phe Arg Thr Met Glu Asp Leu Asp Arg Lys Leu
770 775 780
Leu Lys Val Arg Phe Tyr Ala Lys Pro Lys His Val Arg Cys Trp Ile
785 790 795 800
Pro Arg Ala Pro Arg Ala Val Pro Tyr Lys Ser Arg Tyr Thr Gly Val
805 810 815
Tyr Asp Thr Val Glu Lys Phe Cys Asp Asn Arg Ala Asn Ile Lys Thr
820 825 830
Ala Gly Ala Phe Gly Gln Gln Ser Gly Ala Ala Tyr Val Gly Asn Tyr
835 840 845
Lys Ile Met Asn Arg His Leu Ala Glu Lys Gln Asp Trp Asp Asn Leu
850 855 860
Val Trp Asp Ser Tyr Glu Arg Asp Leu Leu Val Thr Arg Val Asp Ala
865 870 875 880
His Gly Val Asp Gln Ile Ala Arg Cys Asn Cys Arg Ala Gly Val Tyr
885 890 895
Tyr Cys Lys Ser Arg Met Arg His Tyr Pro Val Val Val Thr Pro Pro
900 905 910
Ser Leu Val His Ile Asp Lys Asn Gly Tyr Tyr Pro Glu Arg Tyr Gln
915 920 925
Ser His Val Ala Leu Gly Ile Gly Phe Ala Glu Pro Gly Asp Cys Gly
930 935 940
Gly Leu Leu Arg Cys Glu His Gly Val Met Gly Ile Leu Thr Ala Gly
945 950 955 960
Gly Asn Asn Leu Val Ala Phe Ala Asp Val Arg Asp Leu Leu Trp Ile
965 970 975
Glu Asp Asp Val Met Glu Gln Gly Leu Thr Asp Tyr Val Gln Ser Leu
980 985 990
Gly Asn Ala Phe Gly Ala Gly Phe Thr Asp Glu Ile Ser Asn Tyr Val
995 1000 1005
Gly Gln Val Arg Asp Met Met Ile Gly Ser Asp Thr Val Val Glu Lys
1010 1015 1020
Ile Val Arg Asn Ile Ile Lys Leu Leu Ser Ala Leu Val Ile Val Val
1025 1030 1035 1040
Arg Asn Arg Ala Asp Ile Ile Thr Val Thr Ala Thr Leu Ser Leu Leu
1045 1050 1055
Gly Cys Ser Gly Ser Pro Trp Arg Trp Leu Lys Ser Lys Ile Cys Ser
1060 1065 1070
Ile Leu Gly Ile Asn Met Ala Gln Lys Gln Ala Asp Ser Trp Ile Lys
1075 1080 1085
Lys Phe Thr Glu Ala Val Asn Ala Phe Lys Gly Leu Asp Trp Ile Ala
1090 1095 1100
Ala Lys Phe Ser Lys Phe Leu Asp Trp Ile Lys Ser Lys Ile Ile Pro
1105 1110 1115 1120
Glu Leu Arg Glu Arg Thr Glu Phe Val Lys Asn Leu Arg Gln Leu Pro
1125 1130 1135
Leu Leu Glu Ala Gln Ile Thr Thr Leu Glu His Ser Asn Pro Asn Gln
1140 1145 1150
Glu Thr Gln Glu Thr Leu Phe Ser Asn Val Gln Tyr Leu Ala His His
1155 1160 1165
Cys Arg Lys Asn Ala Pro Leu Tyr Ala Ala Glu Ala Arg Arg Val Phe
1170 1175 1180
Ala Leu Glu Lys Arg Val Leu Gly Ala Met Gln Phe Lys Thr Lys Asn
1185 1190 1195 1200
Arg Ile Glu Pro Val Cys Cys Leu Ile His Gly Thr Pro Gly Thr Gly
1205 1210 1215
Lys Ser Leu Ala Thr Thr Ile Ile Gly Arg Lys Ile Ala Glu Tyr Glu
1220 1225 1230
Asn Ser Gly Val Tyr Ser Leu Pro Pro Asp Pro Asp His Phe Asp Gly
1235 1240 1245
Tyr Gln Glu Gln Ala Val Val Ile Met Asp Asp Leu His Gln Asn Pro
1250 1255 1260
Asp Gly Lys Asp Met Ser Leu Phe Cys Gln Met Val Ser Thr Thr Pro
1265 1270 1275 1280
Phe Val Val Pro Met Ala Ala Leu Glu Asp Lys Gly Arg Leu Phe Thr
1285 1290 1295
Ser Lys Tyr Val Leu Ala Ser Thr Asn Ala Asn His Ile His Pro Val
1300 1305 1310
Thr Val Ala Asp Gly Lys Ala Leu Gln Arg Arg Phe His Phe Asp Thr
1315 1320 1325
Asp Ile Glu Ile Met Asp Gly Tyr Val Gln Asn Gly Lys Leu Asn Ile
1330 1335 1340
Gln Lys Ala Thr Glu Ser Cys Glu Asp Cys Ser Pro Ile Asn Phe Gln
1345 1350 1355 1360
Lys Cys Met Pro Leu Ile Cys Gly Lys Ala Leu Gln Leu Arg Ser Lys
1365 1370 1375
Lys Gly Asp Gly Met Arg Tyr Ser Ile Asp Thr Met Ile Thr Glu Met
1380 1385 1390
Arg Arg Glu Ser Ala Arg Arg Tyr Asn Ile Gly Asn Val Ile Glu Ala
1395 1400 1405
Leu Phe Gln Gly Pro Pro Glu Phe Lys Pro Leu Arg Ile Asp Val Ser
1410 1415 1420
Glu Glu Thr Pro Ala Pro Pro Ala Ile Ala Asp Leu Leu Ala Ser Val
1425 1430 1435 1440
Asp Ser Glu Glu Val Arg Glu Tyr Cys Arg Ser Lys Gly Trp Ile Val
1445 1450 1455
Gln Glu Lys Ile Thr Lys Glu Ser Leu Glu Arg Asn Val Asn Arg Ala
1460 1465 1470
Leu Ile Val Leu Gln Ser Ala Thr Leu Ile Ala Thr Ile Cys Gly Val
1475 1480 1485
Ile Tyr Ile Val Tyr Lys Leu Phe Ala Gly Leu Gln Gly Pro Tyr Ser
1490 1495 1500
Gly Ile His Thr Asn Tyr Gln Lys Val Lys Pro Val Val Arg Gln Val
1505 1510 1515 1520
Thr Thr Gln Gly Pro Leu Val Asp Phe Ala Val Ser Leu Leu Lys Lys
1525 1530 1535
Asn Ile Lys Thr Val Gln Thr Lys Val Gly Glu Phe Thr Gly Leu Gly
1540 1545 1550
Val Tyr Asp Thr Phe Met Val Leu Pro Arg His Ala Met Ala His Asp
1555 1560 1565
Glu Ile Gln Ile Asp Gly Lys Thr Val Lys Ile Glu Asp Ala Tyr Asp
1570 1575 1580
Leu Asn Asp Thr Thr Gln Thr Ser Leu Glu Leu Thr Ile Ile Lys Leu
1585 1590 1595 1600
Lys Gln Asn Glu Arg Phe Arg Asp Ile Arg Ala Met Ile Pro Glu Asn
1605 1610 1615
Ile Thr Glu Thr Ser Glu Ala Leu Val Ile Val Asn Thr Ser Ala Tyr
1620 1625 1630
Pro Asn Leu Phe Met Pro Val Gly Ala Val Lys Asp Tyr Gly Tyr Leu
1635 1640 1645
Asn Leu Ala Gly Arg Pro Thr His Arg Thr Leu Met Tyr Asn Phe Pro
1650 1655 1660
Thr Arg Ala Gly Gln Cys Gly Gly Val Ala Ile Ser Met Gly Lys Ile
1665 1670 1675 1680
Ile Gly Ile His Ile Gly Gly Asn Gly Ala Gln Gly Phe Ser Ala Ala
1685 1690 1695
Leu Leu Arg Arg Tyr Phe Thr Gln Pro Gln Gly Glu Ile Glu Phe Met
1700 1705 1710
Glu Lys Ser Lys Asp Ala Gly Tyr Pro Ile Ile Asn Ala Pro Thr Arg
1715 1720 1725
Thr Lys Leu His Pro Ser Val Phe Tyr Asp Val Phe Pro Gly Glu Lys
1730 1735 1740
Glu Pro Ala Val Leu His Lys Lys Asp Pro Arg Leu Glu Val Asp Phe
1745 1750 1755 1760
Glu Glu Ala Leu Phe Ser Lys Tyr Ile Gly Asn Lys His Ile Ala Val
1765 1770 1775
Thr Glu Glu Met Glu Ile Ala Ile Asp His Tyr Ala Asn Gln Leu Lys
1780 1785 1790
Gln Leu Asp Ile Asp Pro Ser Pro Ile Ser Met Glu Asp Ala Ile Tyr
1795 1800 1805
Gly Thr Glu Gly Leu Glu Ala Leu Asp Leu Gly Thr Ser Ala Gly Tyr
1810 1815 1820
Pro Tyr Val Ala Leu Gly Ile Lys Lys Arg Asp Ile Leu Asn Lys Glu
1825 1830 1835 1840
Thr Arg Asp Val Ser Lys Met Gln Gln Cys Ile Asp Lys Tyr Gly Leu
1845 1850 1855
Asn Leu Pro Met Val Thr Tyr Val Lys Asp Glu Leu Arg Ser Lys Glu
1860 1865 1870
Lys Val Lys Lys Gly Lys Ser Arg Leu Ile Glu Ala Ser Ser Leu Asn
1875 1880 1885
Asp Ser Val Ala Met Arg Cys Ala Phe Gly Asn Leu Tyr Lys Ala Phe
1890 1895 1900
His Thr Asn Pro Gly Thr Leu Thr Gly Cys Ala Val Gly Cys Asn Pro
1905 1910 1915 1920
Glu Thr Phe Trp Ser Lys Ile Pro Val Met Met Asp Gly Glu Leu Phe
1925 1930 1935
Gly Phe Asp Tyr Thr Ala Tyr Asp Ala Ser Leu Ser Pro Val Trp Phe
1940 1945 1950
Gln Cys Leu Tyr Leu Leu Leu Glu Lys Ile Gly Phe Gly His Cys Lys
1955 1960 1965
His Phe Ile Asp Gln Leu Cys Cys Ser Asn His Leu Phe Met Asp Lys
1970 1975 1980
Arg Tyr Val Val Val Gly Gly Met Pro Ser Gly Cys Ser Gly Thr Ser
1985 1990 1995 2000
Ile Phe Asn Ser Met Ile Asn Asn Ile Ile Ile Arg Thr Leu Val Leu
2005 2010 2015
Thr Val Tyr Lys Asn Ile Asp Leu Asp Asp Leu Lys Ile Ile Ala Tyr
2020 2025 2030
Gly Asp Asp Val Ile Ala Ser Tyr Pro Phe Glu Leu Asp Ala Lys Leu
2035 2040 2045
Leu Ala Asp Ala Gly Lys Ser Phe Gly Leu Ile Met Thr Pro Pro Asp
2050 2055 2060
Lys Ser Ala Glu Phe Val Lys Leu Thr Trp Asp Asn Val Thr Phe Leu
2065 2070 2075 2080
Lys Arg Ser Phe Val Lys Asp Glu Arg Phe Pro Phe Leu Ile His Pro
2085 2090 2095
Val Met Lys Met Ser Asp Ile His Glu Ser Ile Arg Trp Thr Lys Asp
2100 2105 2110
Ala Lys Ser Thr Gln Asp His Val Arg Ser Leu Cys Leu Leu Ala Trp
2115 2120 2125
His Cys Gly Gln Glu Gln Tyr Glu Glu Phe Leu Glu Lys Ile Arg Ser
2130 2135 2140
Val Pro Val Gly Arg Ala Leu Ser Leu Pro Ser Phe Lys Ala Leu Gln
2145 2150 2155 2160
Arg Ser Trp Tyr Asp Ser Phe
2165

Claims (8)

1.一种牛肠道病毒分离株HB1901,该病毒的分类命名为牛肠道病毒bovineenterovirus(BEV),该病毒已于2020年7月17日在中国典型培养物保藏中心(CCTCC)进行的保藏,保藏编号为CCTCC NO:V202028。
2.权利要求1 所述牛肠道病毒分离株HB1901的基因,其特征在于,序列如SEQ ID NO.1所示。
3.根据权利要求2 所述牛肠道病毒分离株HB1901的基因,其特征在于,所述病毒的基因序列中插入有GFP。
4.含有权利要求1-3任一所述牛肠道病毒分离株HB1901的载体。
5.权利要求2所述牛肠道病毒分离株HB1901基因翻译的氨基酸序列,其特征在于,序列如SEQ ID NO.2 所示。
6.含有权利要求4所述载体的重组菌或重组细胞。
7.根据权利要求6所述的重组细胞,其特征在于,所述重组细胞为牛肾细胞。
8.权利要求1所述牛肠道病毒分离株HB1901在构建病毒载体中的应用。
CN202210114436.8A 2022-01-30 2022-01-30 一种牛肠道病毒分离株及其应用 Pending CN115058397A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210114436.8A CN115058397A (zh) 2022-01-30 2022-01-30 一种牛肠道病毒分离株及其应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210114436.8A CN115058397A (zh) 2022-01-30 2022-01-30 一种牛肠道病毒分离株及其应用

Publications (1)

Publication Number Publication Date
CN115058397A true CN115058397A (zh) 2022-09-16

Family

ID=83197344

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210114436.8A Pending CN115058397A (zh) 2022-01-30 2022-01-30 一种牛肠道病毒分离株及其应用

Country Status (1)

Country Link
CN (1) CN115058397A (zh)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100121823A (ko) * 2009-05-11 2010-11-19 대한민국(관리부서 : 농림수산식품부 국립수의과학검역원) 소 엔테로바이러스를 이용한 재조합 바이러스 벡터 및 그 제조방법
CN102776155A (zh) * 2011-05-10 2012-11-14 中国农业科学院哈尔滨兽医研究所 牛肠道病毒中国分离株及其感染性cDNA克隆的构建和应用
CN110452889A (zh) * 2019-07-19 2019-11-15 中国农业科学院北京畜牧兽医研究所 一种表达bvdv-e0的重组牛肠道病毒的构建方法与初步应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100121823A (ko) * 2009-05-11 2010-11-19 대한민국(관리부서 : 농림수산식품부 국립수의과학검역원) 소 엔테로바이러스를 이용한 재조합 바이러스 벡터 및 그 제조방법
CN102776155A (zh) * 2011-05-10 2012-11-14 中国农业科学院哈尔滨兽医研究所 牛肠道病毒中国分离株及其感染性cDNA克隆的构建和应用
CN110452889A (zh) * 2019-07-19 2019-11-15 中国农业科学院北京畜牧兽医研究所 一种表达bvdv-e0的重组牛肠道病毒的构建方法与初步应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHENGYUAN JI等: "Isolation and Identification of Type F Bovine Enterovirus from Clinical Cattle with Diarrhoea" *
JI,C.等: "Bovine enterovirus HB19-1, complete genome" *

Similar Documents

Publication Publication Date Title
CN103266091B (zh) A型口蹄疫重组疫苗株及其制备方法和应用
CN112011521A (zh) 一种重组新城疫病毒载体新型冠状病毒疫苗候选株及其构建方法和应用
CN110218706B (zh) 表达h7n9亚型高致病性禽流感病毒ha蛋白的重组火鸡疱疹病毒的构建与应用
CN113201507A (zh) 一种重组的伪狂犬病病毒及其疫苗组合物
CN112458064A (zh) 盖他病毒全长感染性克隆、复制子系统及其制备和应用
CN114807060B (zh) 柯萨奇病毒a6型毒株及其免疫原性组合物和应用
CN110468155B (zh) 一种用于拯救猪肠道甲型冠状病毒的系统、方法及应用
CN113564133B (zh) 柯萨奇病毒a16型毒株及其免疫原性组合物和应用
CN109628414B (zh) 一种mRNA甲基转移酶缺陷型腮腺炎病毒及其制备方法和应用
CN113817753B (zh) 表达SARS-CoV-2纤突蛋白或其变异体SΔ21的假型化VSV病毒构建和应用
CN110747175A (zh) 一株猪δ冠状病毒及其应用
CN111773383B (zh) 一种o型口蹄疫亚单位疫苗及其制备方法和应用
CN106939320B (zh) 一种伪狂犬病毒js-2012株感染性克隆质粒、构建方法与应用
CN111454982B (zh) 一种包含非洲猪瘟病毒免疫原性蛋白的重组载体、重组菌及其应用
CN111073862B (zh) 一种牛病毒性腹泻2型减毒毒株及应用
CN107298700A (zh) 人工改造的PCV2 Rep蛋白、重组PCV2病毒及其应用
CN109943576A (zh) 一种嵌合犬瘟热病毒主要免疫基因的重组狂犬病病毒及其应用
CN115058397A (zh) 一种牛肠道病毒分离株及其应用
CN113214407B (zh) Ii型草鱼呼肠孤病毒vp4-ns38融合蛋白基因、表达载体、菌株及其应用
CN115094045A (zh) 耐热的嵌合型基因vii型新城疫弱毒株及其应用
CN110904056B (zh) 一种传染性支气管炎病毒rH120-YZS1Δ5a及其构建方法和应用
CN114214338A (zh) 猪源piv5全长感染性克隆及其制备方法和应用
CN110013547B (zh) 一株重组小反刍兽疫病毒h基因的粗糙型布鲁氏菌及其疫苗生产方法
CN109939225B (zh) 一株重组鹦鹉热衣原体外膜蛋白momp基因的粗糙型布鲁氏菌及其疫苗生产方法
CN113462660A (zh) 表达禽传染性支气管炎病毒s蛋白重组新城疫载体疫苗、制备方法及应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20220916